Biostax Corp (BTAX)

[noreen]

I dont know. It doesnt say USA or Africa or whom loaned the money. If it was cytocom I could live with it.

It says "IRT-103". This is ONLY the name for LDN in the United States through Cytocom. This is why it is ONLY 2% of sales through Cytocom. Because IRT-103 is not the correct name for the drug in Africa. In Africa, it is called "Lodonal" TM. Same drug of course.

But all of the bonds in default are not being forclosed on. Whats up with that?

Are you asking why the notes in the "Notes Payable" section say "No demands for repayment have been made by the lenders" for loans in default?

I can only speculate, but the Notes Payable section has looked like that for a while now. Look at old 10-q's and 10-k's.

And it is a VERY GOOD THING that our lenders do not demand repayment on loans in default. It means they are on the same side as the company. I can only speculate as to why, but it seems that our lenders / creditors are very confident that our revenue stream will begin soon enough - this would be the only reason I can think of in which they do not seem worried about loans that are in default. Can anyone else think of a different reason?